InvestorsHub Logo
Post# of 252816
Next 10
Followers 27
Posts 5261
Boards Moderated 1
Alias Born 08/02/2006

Re: None

Thursday, 03/10/2011 10:39:36 AM

Thursday, March 10, 2011 10:39:36 AM

Post# of 252816
AMLN... once a month formulation gives 1.3-1.5% average A1C reduction.

That seems like a big deal.

AMLN must be pulling their hair out focusing on that 1.5% number for Victoza.

This had a Bydureon arm and they are quick to point out that they hit 1.5% there too.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.